MediFind found 46 doctor with experience in Chronic Myelogenous Leukemia (CML) near Pittsburgh, PA. Of these, 40 are Experienced and 6 are Advanced.
UPMC Hillman Cancer Center
James M. Rossetti, DO, is a hematologist specializing in the treatment of hematological malignancies and myeloid diseases, including myelodysplasia, acute myeloid leukemia, and myeloproliferative neoplasm. He also specializes in cellular therapy. Dr. Rossetti is a referral physician for the UPMC MDS Center of Excellence. Dr. Rossetti is rated as an Advanced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Acute Myeloid Leukemia (AML), Multiple Myeloma, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant.
UPMC Hillman Cancer Center
Kelly G. Ross, MD, specializes in hematology oncology and is board-certified in hematolgoy and medical oncology by the American Board of Internal Medicine. She is affiliated with UPMC Shadyside and UPMC Presbyterian. Dr. Ross completed her fellowship at the University of Colorado and residency and medical degree at the University of Pittsburgh School of Medicine. Dr. Ross is rated as an Advanced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Mantle Cell Lymphoma (MCL), Bone Marrow Aspiration, and Bone Marrow Transplant.
UPMC Hillman Cancer Center
Shannon L. Puhalla, MD, is assistant professor of medicine at the University of Pittsburgh School of Medicine, and a medical oncologist and hematologist at UPMC Hillman Cancer Center. She specializes in breast oncology, Phase I clinical trials, and novel therapeutics in breast cancer. Dr. Puhalla is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.
Classical Hematology
Roy E. Smith, MD, is a professor of medicine at the University of Pittsburgh School of Medicine in the Division of Hematology/Oncology. Dr Smith specializes in bleeding and thrombotic disorders, Rare Homologic Diseases, Chronic Leukemia and Myelodyplasia. Dr. Smith is board-certified in internal medicine, medical oncology, and hematology. He received his medical degree from The Ohio State University, Columbus, and his Master of Science degree from the University of Wisconsin, College of Medicine, Madison. He completed his residency in medical oncology and his fellowship in hematology oncology, both at The Ohio State University. He is the former director of the Ohio State University Hospital's Special Coagulation Laboratory and its Hemophilia Center. He presently serves as chairman of the Central Investigational Review Board for the Cancer Therapeutics and Development branch of the National Cancer Institute and has served on the Peripheral and Central Nervous System Drug Advisory Committee and the Oncologic Drug Advisory Committee of the FDA. Dr. Smith serves as the co-chair of the Anticoagulation Task Force for the Presbyterian Hospital and its affiliates and chair of the Anticoagulation Working Group of the system-wide P and T committee. Dr. Smith is a member of the American Society of Hematology, the American Society of Clinical Oncology, the Society for Scientific Exploration, The International Society of Thrombosis and Hemostasis, the American Medical Association and the American Society for Apheresis, and the American College of Chest Physicians. He is a Fellow of the American College of Physicians and the International Academy of Clinical and Applied Thrombosis and Hemostasis. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Venous Thromboembolism (VTE), Acute Hepatic Porphyria (AHP), Shwartzman Phenomenon, and Porphyria.
Oncology Hematology Association Inc
Mounzer Agha is a Hematologist in Pittsburgh, Pennsylvania. Dr. Agha is rated as an Advanced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Oncology Hematology Association Inc
Anastasios Raptis is a Hematologist Oncology specialist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Raptis is rated as an Advanced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
Allegheny Clinic
John Lister is a Hematologist Oncology specialist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Lister is rated as an Advanced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Acute Myeloid Leukemia (AML), Multiple Myeloma, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration.
Allegheny Clinic
Cyrus Khan is a Hematologist Oncology specialist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Khan is rated as an Advanced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Relapsed Refractory Multiple Myeloma (RRMM), Chronic B-Cell Leukemia (CBCL), Bone Marrow Aspiration, and Bone Marrow Transplant.
UPMC Hillman Cancer Center
Jing-Zhou Hou, MD, PhD, is a clinical hematological oncologist specializing in hematological malignancies, cell therapy, and bone marrow transplant in the Mario Lemieux Center for Blood Cancers at UPMC Hillman Cancer Center. Dr. Hou received his medical degree from Henan Medical University in China, his master’s degree at Shanghai Medical University, and his PhD in Molecular and Cell Biology from Tulane University. He completed his internal medicine residency in Northeastern Ohio University College of Medicine, and fellowship in Hematology and Oncology at Stanford University. He joined UPMC Hillman Cancer Center in 2007. Dr. Hou is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant.
UPMC Hillman Cancer Center
Robert Redner is a Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Redner is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Redner is currently accepting new patients.
UPMC Hillman Cancer Center
Sawa Ito, MD, PhD, specializes in hematology oncology and medical oncology and is board-certified by the American Board of Internal Medicine. She practices at UPMC Hillman Cancer Center and is affiliated with UPMC Presbyterian, UPMC Magee-Womens Hospital, and UPMC Shadyside. Dr. Ito received her medical degree from Hokkaido University and completed residencies at Teine Keijinkai Hospital and the University of Pittsburgh School of Medicine, followed by a fellowship at the National Institutes of Health. Dr. Ito is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). Her top areas of expertise are Graft Versus Host Disease (GvHD), Leukemia, Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
UPMC Hillman Cancer Center
Alison Sehgal, MD, is an assistant professor of medicine at the University of Pittsburgh School of Medicine, and a hematologist/medical oncologist specializing in allogeneic and autologous stem cell transplant, lymphoma, leukemia, and multiple myeloma. Dr. Sehgal is conducting research in stem cell transplant and drug development in hematologic malignancies. Dr. Sehgal is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). Her top areas of expertise are Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), B-Cell Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
UPMC Hillman Cancer Center
Annie Im, MD, is an Associate Professor of Medicine at the University of Pittsburgh School of Medicine, and a hematologist/medical oncologist specializing and conducting research in hematologic malignancies (such as acute leukemia), drug development, stem cell transplantation, and graft-versus-host-disease. In addition, Dr. Im leads the chronic graft-versus-host-disease and stem cell transplant survivorship clinic. Dr. Im is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). Her top areas of expertise are Acute Myeloid Leukemia (AML), Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Bone Marrow Aspiration, and Bone Marrow Transplant.
UPMC Hillman Cancer Center
Donald Woytowitz, Jr., MD, is a hematologist/oncologist at UPMC Hillman Cancer Center. He specializes in myeloproliferative disorders, myelodysplastic syndromes, benign hematology, and non-Hodgkin lymphoma. Dr. Woytowitz is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Polycythemia Vera, Thrombocytopenia, Essential Thrombocythemia, and Monoclonal Gammopathy of Undetermined Significance (MGUS).
Classical Hematology
Steven Fein, MD, specializes in hematology oncology and is board certified in internal medicine, medical oncology, hematology, and hospice and palliative medicine by the American Board of Internal Medicine. He practices at University of Pittsburgh Physicians, Department of Hematology Oncology. Dr. Fein completed his fellowship at University of Miami Miller School of Medicine at Jackson Memorial Hospital, residency at Duke University Medical Center, and medical education at Johns Hopkins University School of Medicine. Dr. Fein is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Bone Marrow Aspiration, and Splenectomy.
Andrew Joseph is a primary care provider, practicing in Internal Medicine in Pittsburgh, Pennsylvania. Dr. Joseph is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Cirrhosis, Familial Combined Hyperlipidemia, Xanthoma, and Achilles Tendon Rupture.
Oncology Hematology Association Inc
Rafic Farah is an Oncologist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Farah is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
Allegheny Clinic
Salman Fazal is a Hematologist Oncology specialist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Fazal is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Acute Myeloid Leukemia (AML), Myelofibrosis, Aplastic Anemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
Allegheny Clinic
Santhosh Sadashiv is a Hematologist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Sadashiv is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Aplastic Anemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
Allegheny Clinic Medical Oncology
Hashem Younes is a Hematologist Oncology specialist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Younes is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Melanoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Squamous Cell Lung Carcinoma.
Last Updated: 10/30/2025









